Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion type Assertion NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_head.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion description "[In eight of these (80%) additional juxtapositioned nuclear factor 1, glial factor 1 and/or AP-1 binding motifs were created by duplications and/or insertions in region D. These findings indicate that type II TCRs are frequently present in PML and suggest to use TCR type II constructs for in vitro and in vivo studies of the evaluation of the functional role of DNA binding motifs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_provenance.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion evidence source_evidence_literature NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_provenance.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion SIO_000772 11031693 NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_provenance.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion wasDerivedFrom befree-20140225 NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_provenance.
- NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_assertion wasGeneratedBy ECO_0000203 NP591050.RACuKxa2Zi_KKCRXDGBmoGYGO2hrBxssSD4CAL_NK_aNY130_provenance.